Foot pump patent dispute back in court
This article was originally published in Clinica
Orthofix International subsidiary Novamedix has re-opened litigation against its competitor Kinetic Concepts in a case that was first launched in 1992. It alleges Kinetic has breached the patents on Novamedix's A-V Impulse, a foot pump used to treat deep vein thrombosis. The Texas Federal Court had delayed the case until the US Patent Office re-examined the patents at Kinetic's request, says Novamedix, of New York. Novamedix says three out of four of its patents have been confirmed valid. It is claiming damages of $100 million from Kinetic.
You may also be interested in...
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.